Milind Deshpande
CIK 1378588 · Chief Executive Officer · last filed 2025-06-16
Milind Deshpande is a Chief Executive Officer who has filed 31 SEC Form 4 insider transactions across 3 companies since 2007. The most recent filing, for SPRO, was dated Jun 16, 2025. Across all open-market trades the lifetime net is −$4.7M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $260.6K across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$260.6K
3
31
-$4.67M
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| SPRO | Director | 91,454 | $2.85 | $260.6K | $0 | 10 | 2025-06-16 |
| ACHILLION PHARMACEUTICALS INC (ACHN) Delisted | Chief Executive Officer | 2,500 | — | — | -$4.67M | 18 | 2018-02-13 |
| ACHILLION PHARMACEUTICALS INC (TPTX) Delisted | EVP and CSO | — | $76.01 | — | $0 | 3 | 2008-12-17 |
Recent Filings
31 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2025-06-16 | SPRO | Grant (A) | +20,000 | $0 | EDGAR |
| 2024-05-30 | SPRO | Grant (A) | +20,000 | $0 | EDGAR |
| 2023-10-10 | SPRO | Grant (A) | +20,000 | $0 | EDGAR |
| 2022-09-19 | SPRO | Grant (A) | +15,000 | $0 | EDGAR |
| 2021-08-18 | SPRO | Grant (A) | — | $0 | EDGAR |
| 2021-01-06 | SPRO | Grant (A) | — | $0 | EDGAR |
| 2020-10-27 | SPRO | Grant (A) | — | $0 | EDGAR |
| 2020-01-06 | SPRO | Grant (A) | — | $0 | EDGAR |
| 2019-06-05 | SPRO | Grant (A) | — | $0 | EDGAR |
| 2018-06-06 | SPRO | Grant (A) | — | $0 | EDGAR |